MedPath

Serodus AS

๐Ÿ‡ณ๐Ÿ‡ดNorway
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:0
Completed:2

Trial Phases

1 Phases

Phase 2:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)โ€ข Click on a phase to view related trials

Phase 2
2 (100.0%)

SER150 vs Placebo in Diabetic Kidney Disease

Phase 2
Completed
Conditions
Diabetic Kidney Disease
Interventions
Drug: Placebo
First Posted Date
2021-05-11
Last Posted Date
2024-06-21
Lead Sponsor
Serodus AS
Target Recruit Count
20
Registration Number
NCT04881123
Locations
๐Ÿ‡ฆ๐Ÿ‡บ

Liverpool Hospital, Liverpool, New South Wales, Australia

๐Ÿ‡ฆ๐Ÿ‡บ

The AIM Centre (Hunter Diabetes Centre), Merewether, New South Wales, Australia

๐Ÿ‡ฆ๐Ÿ‡บ

Royal North Shore Hospital, Saint Leonards, New South Wales, Australia

and more 9 locations

SER100 in Isolated Systolic Hypertension

Phase 2
Completed
Conditions
Isolated Systolic Hypertension
Interventions
Drug: Placebo
First Posted Date
2013-11-19
Last Posted Date
2016-10-20
Lead Sponsor
Serodus AS
Target Recruit Count
17
Registration Number
NCT01987284
Locations
๐Ÿ‡ซ๐Ÿ‡ฎ

FinnMedi Oy/Valkeakoski District Hospital, Tampere, Finland

๐Ÿ‡ซ๐Ÿ‡ฎ

CRST/Turku University Hospital, Turku, Finland

๐Ÿ‡ญ๐Ÿ‡บ

Semmelweiss University Hospital, Budapest, Hungary

and more 4 locations

News

No news found
ยฉ Copyright 2025. All Rights Reserved by MedPath